HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study
- PMID: 31462492
- PMCID: PMC6712507
- DOI: 10.1136/bmj.l4894
HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study
Abstract
Objective: To evaluate if the lowest target level for glycated haemoglobin (HbA1c) of <6.5% is associated with lower risk for retinopathy and nephropathy than less tight control in children and adults with type 1 diabetes.
Design: Population based cohort study.
Setting: Swedish National Diabetes Registry, 1 January 1998 to 31 December 2017.
Participants: 10 398 children and adults with type 1 diabetes followed from diagnosis, or close thereafter, until end of 2017.
Main outcome measures: Relative risk (odds ratios) for retinopathy and nephropathy for different mean levels of HbA1c.
Results: Mean age of participants was 14.7 years (43.4% female), mean duration of diabetes was 1.3 years, and mean HbA1c level was 8.0% (63.4 mmol/mol). After adjustment for age, sex, duration of diabetes, blood pressure, blood lipid levels, body mass index, and smoking, the odds ratio for mean HbA1c <6.5% (<48 mmol/mol) compared with 6.5-6.9% (48-52 mmol/mol) for any retinopathy (simplex or worse) was 0.77 (95% confidence interval 0.56 to 1.05, P=0.10), for preproliferative diabetic retinopathy or worse was 3.29 (0.99 to 10.96, P=0.05), for proliferative diabetic retinopathy was 2.48 (0.71 to 8.62, P=0.15), for microalbuminuria or worse was 0.98 (0.60 to 1.61, P=0.95), and for macroalbuminuria was 2.47 (0.69 to 8.87, P=0.17). Compared with HbA1c levels 6.5-6.9%, HbA1c levels 7.0-7.4% (53-57 mmol/mol) were associated with an increased risk of any retinopathy (1.31, 1.05 to 1.64, P=0.02) and microalbuminuria (1.55, 1.03 to 2.32, P=0.03). The risk for proliferative retinopathy (5.98, 2.10 to 17.06, P<0.001) and macroalbuminuria (3.43, 1.14 to 10.26, P=0.03) increased at HbA1c levels >8.6% (>70 mmol/mol). The risk for severe hypoglycaemia was increased at mean HbA1c <6.5% compared with 6.5-6.9% (relative risk 1.34, 95% confidence interval 1.09 to 1.64, P=0.005).
Conclusions: Risk of retinopathy and nephropathy did not differ at HbA1c levels <6.5% but increased for severe hypoglycaemia compared with HbA1c levels 6.5-6.9%. The risk for severe complications mainly occurred at HbA1c levels >8.6%, but for milder complications was increased at HbA1c levels >7.0%.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: ML has received grants from AstraZeneca, Dexcom, Novo Nordisk, and Pfizer, and consulting fees from AstraZeneca, Dexcom, Eli Lilly, MSD, Novo Nordisk, and Rubin Medical; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden).Diabetes Care. 2015 Feb;38(2):308-15. doi: 10.2337/dc14-1203. Epub 2014 Dec 15. Diabetes Care. 2015. PMID: 25510400
-
The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.Diabetes Res Clin Pract. 1997 Mar;35(2-3):113-21. doi: 10.1016/s0168-8227(97)01386-7. Diabetes Res Clin Pract. 1997. PMID: 9179466
-
A high mean-HbA1c value 3-15 months after diagnosis of type 1 diabetes in childhood is related to metabolic control, macroalbuminuria, and retinopathy in early adulthood--a pilot study using two nation-wide population based quality registries.Pediatr Diabetes. 2014 May;15(3):229-35. doi: 10.1111/pedi.12085. Epub 2013 Sep 30. Pediatr Diabetes. 2014. PMID: 24119008
-
Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.Endocr Pract. 2006 Jan-Feb;12 Suppl 1:34-41. doi: 10.4158/EP.12.S1.34. Endocr Pract. 2006. PMID: 16627378 Review.
-
[Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus].Wien Med Wochenschr. 2010 Aug;160(15-16):414-8. doi: 10.1007/s10354-010-0816-z. Wien Med Wochenschr. 2010. PMID: 20812053 Review. German.
Cited by
-
What is the Relationship Between Time in Range, Time in Tight Range, and HbA1c in Youth and Young Adults With Type 1 Diabetes? Results From the German/Austrian/Luxembourgian/Swiss Diabetes Prospective Follow-Up Registry.J Diabetes Sci Technol. 2024 Nov 16:19322968241288870. doi: 10.1177/19322968241288870. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 39548894 Free PMC article.
-
Hemoglobin A1c Genetics and Disparities in Risk of Diabetic Retinopathy in Individuals of Genetically Inferred African American/African British and European Ancestries.Diabetes Care. 2024 Oct 1;47(10):1731-1739. doi: 10.2337/dc23-1691. Diabetes Care. 2024. PMID: 39042486
-
Plasma matrix metalloproteinases and tissue inhibitors of metalloproteinases explored in relation to the severity and progression of diabetic retinopathy in patients with type 1 diabetes: baseline and prospective analyses.BMJ Open Ophthalmol. 2024 Jul 11;9(1):e001583. doi: 10.1136/bmjophth-2023-001583. BMJ Open Ophthalmol. 2024. PMID: 38991835 Free PMC article.
-
Advanced cardiovascular physiology in an individual with type 1 diabetes after 10-year ketogenic diet.Am J Physiol Cell Physiol. 2024 Aug 1;327(2):C446-C461. doi: 10.1152/ajpcell.00694.2023. Epub 2024 Jun 24. Am J Physiol Cell Physiol. 2024. PMID: 38912731
-
BREATHE-T1D: Using iterative mixed methods to adapt a mindfulness-based intervention for adolescents with type 1 diabetes: Design and development.Contemp Clin Trials. 2024 Jul;142:107551. doi: 10.1016/j.cct.2024.107551. Epub 2024 Apr 29. Contemp Clin Trials. 2024. PMID: 38692428
References
-
- Nathan DM, Genuth S, Lachin J, et al. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86. 10.1056/NEJM199309303291401 - DOI - PubMed
-
- Nordwall M, Abrahamsson M, Dhir M, Fredrikson M, Ludvigsson J, Arnqvist HJ. Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care 2015;38:308-15. 10.2337/dc14-1203. - DOI - PubMed
-
- Lind M, Odén A, Fahlén M, Eliasson B. A systematic review of HbA1c variables used in the study of diabetic complications. Diabetes Metab Syndr 2008;2:282-93 10.1016/j.dsx.2008.04.006. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous